AXGN vs SRPT · rev $131.2M vs rev $1.13B
Axogen Inc (AXGN) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Axogen Inc (AXGN) is a medical devices company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported AXGN revenue for 2026-06-30 was $131.2M. Net income was -$21.1M. AXGN currently screens at market cap $497.8M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
AXGN currently screens at market cap $497.8M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the AXGN and SRPT stock pages for the full models.
Not investment advice.